Number of items: 4.
2023
Wong, Serre-Yu,
Wellens, Judith,
Helmus, Drew,
Marlow, Luke,
Brann, Stephanie,
Martinez Pazos, Vicky,
Weinberg, Alan,
Moran, Hunter R.,
McGregor, Colleen,
Vermeire, SΓ©verine et al.
(2023)
Geography influences susceptibility to SARS-CoV-2 serological response in patients with inflammatory bowel disease : multinational analysis from the ICARUS-IBD Consortium.
Inflammatory Bowel Diseases, 29
(11).
pp. 1693-1705.
doi:
10.1093/ibd/izad097
ISSN 1078-0998.
Thompson, R. N., Southall, E., Daon, Y., Lovell-Read, F. A., Iwami, S., Thompson, C. P. and Obolski, U.
(2023)
The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants.
Frontiers in Immunology, 13
.
1049458.
doi:10.3389/fimmu.2022.1049458
ISSN 1664-3224.
2022
McNaughton, Anna L.,
Paton, Robert S.,
Edmans, Matthew,
Youngs, Jonathan,
Wellens, Judith,
Phalora, Prabhjeet,
Fyfe, Alex,
Belij-Rammerstorfer, Sandra,
Bolton, Jai S.,
Ball, Jonathan et al.
(2022)
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses.
JCI Insight, 7
(13).
e156372.
doi:
10.1172/jci.insight.156372
ISSN 2379-3708.
2021
Wellens, Judith, Edmans, Matthew, Obolski, Uri, McGregor, Colleen G. C., Simmonds, Peter, Turner, Marc, Jarvis, Lisa, Skelly, Donal, Dunachie, Susanna, Barnes, Eleanor, Eyre, David W, Colombel, Jean-Frederic, Wong, Serre-Yu, Klenerman, Paul, Lindsay, James O., Satsangi, Jack and Thompson, Craig P.
(2021)
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.
Gut, 71
(9).
pp. 1919-1922.
ISSN 0017-5749
doi:10.1136/gutjnl-2021-326312
This list was generated on Wed Apr 24 07:19:48 2024 BST.